Home Business Wall Street Pares Interest Rate Cut Expectations Ahead of Powell’s Jackson Hole Speech
BusinessEconomic PoliciesMarketsStocks

Wall Street Pares Interest Rate Cut Expectations Ahead of Powell’s Jackson Hole Speech

Share
wall-street-pares-interest-rate-cut-expectations-ahead-of-powell’s-jackson-hole-speech
Wall Street Pares Interest Rate Cut Expectations Ahead of Powell’s Jackson Hole Speech
Share

‘I think we’ve got some work to do,’ Kansas City Fed President Jeffrey Schmid said.

Wall Street Pares Interest Rate Cut Expectations Ahead of Powell’s Jackson Hole Speech

Federal Reserve Chairman Jerome Powell testifies before the House Committee on Monetary Policy in Washington on Feb. 12, 2025. Madalina Vasiliu/The Epoch Times

Andrew Moran

|Updated:

Investors pared their interest rate cut expectations ahead of Federal Reserve Chair Jerome Powell’s speech at the annual Jackson Hole retreat.

New CME FedWatch Tool data show the futures markets now assign a 74 percent probability to a quarter-point reduction in the federal funds rate—a key benchmark for borrowing costs that stands in a target range of 4.25 and 4.5 percent—at the September policy meeting.

Andrew Moran

Andrew Moran has been writing about business, economics, and finance for more than a decade. He is the author of “The War on Cash.”

Author’s Selected Articles

Share
Related Articles
usda-unveils-new-support-for-ranchers-to-rebuild-cattle-herds
BusinessEconomyUSUS News

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new package of measures...

how-major-us-stock-indexes-fared-aug.-31
BrightBusinessInvestingMarketsPersonal FinanceStocks

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American forces struck Iranian...

trump-unveils-new-drug-pricing-deals-with-9-pharmaceutical-companies
BusinessCompaniesExecutive BranchUSUS NewsUS Politics

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...